Site 120 — Miami, Florida

Public research footprint of Site 120, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Metastatic Castration-Resistant Prostate Cancer (mCRPC) · Non-Clear Cell Renal Cell Carcinoma (nccRCC) · Adjunctive Treatment of Major Depressive Disorder · Chronic Plaque Psoriasis

Recently updated registry entries

NCT06822790 — Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia (Recruiting)
NCT05176483 — Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With… (Recruiting)
NCT06439602 — Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-302) (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Site 120?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.